Delivery Order SPE2DB22D1017-SPE2DB24FF4VZ
Award Date 3/25/24
Potential Completion Date 3/26/24
Potential Value $5.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company AmerisourceBergen Corporation. The $10,538.64 firm fixed price delivery order is for the supply of GLATOPA 40 MG/ML syringes, a specialty pharmaceutical product. The award has a performance period through March 26, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $23,478.45 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) for the supply of GLATOPA 40 MG/ML syringes. The award has no set-aside designation. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of GLATOPA 40 MG/ML syringes. The $5,400.00 firm fixed-price delivery order has an ultimate completion date of April 22, 2024 and does not utilize any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025....
- This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,030.03 firm fixed price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product, to support the requirements of the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLATOPA 40 MG/ML syringes. The $114,377.91 order was placed on May 26, 2022, with a completion date of May 27, 2022. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to various U.S. government agencies, primarily the Department of...
- This federal contract award is a delivery order issued under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This award, valued at $2,731.87, is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, to support military treatment programs and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,465.28 firm-fixed-price delivery order is for the supply of 4565747861 - GEL-ONE 30 MG/3 ML SYRINGE 3ML. This product is being provided to support military treatment facilities and other federal healthcare providers. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
- This federal contract award, valued at $2,645.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,473.50 fixed-price delivery order contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 mg/0.75 ml pens. The firm-fixed-price delivery order has a ceiling value of $4,621.43 and an ultimate completion date of July 31, 2024. The contract does not have a set-aside designation. As a large indefinite delivery contract (IDC) holder with the DLA Troop Support Medical, valued up to $999,999,999, AmerisourceBergen is...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4VZDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The award, valued at $5,650.68, is a firm fixed price delivery order for the supply of GLATOPA 40 mg/ml syringes. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, that serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award is a task order issued under that IDC. The contract does not have a set-aside designation.
Generated 6/24/24, 9:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 3/25/24 |